Description:

NSABP PROTOCOL B-36 Treatment Form for 5-FU, Epirubicin, Cyclophosphamide (FEC) Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C87B6D74-9381-59FA-E034-0003BA12F5E7

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C87B6D74-9381-59FA-E034-0003BA12F5E7
Keywords:
  1. 8/26/12 8/26/12 -
  2. 12/12/14 12/12/14 - Martin Dugas
  3. 1/8/15 1/8/15 - Martin Dugas
Uploaded on:

January 8, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00087178 Treatment - NSABP PROTOCOL B-36 Treatment Form for 5-FU, Epirubicin, Cyclophosphamide (FEC) - 2174958v3.0

No Instruction available.

  1. StudyEvent: NSABP PROTOCOL B-36 Treatment Form for 5-FU, Epirubicin, Cyclophosphamide (FEC)
    1. No Instruction available.
General information
Are data amended?
Summary Of 5-fu, Epirubicin, Cyclophosphamide
Cycle #
Unnamed question [agent name]
Was this cycle delayed for toxicity? (Circle Y or N for Yes, No)
Was growth factor support employed? (Circle Y or N for Yes, No)
Summary Of 5-fu, Epirubicin, Cyclophosphamide (continued)
Reason Treatment Ended (Select the reason that best explains why FEC has ended, or why the patient did not begin FEC.)

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial